Diabetes
Saidal, Novo Nordisk Algeria sign agreement on production of innovative treatments
Wednesday, July 01, 2026 08:21

ALGIERS - Saidal Group signed a partnership agreement on Tuesday, in Algiers, with Novo Nordisk Algeria for the joint production and distribution of innovative molecules intended for the treatment of patients with diabetes and obesity, the group said in a statement.
Subscriber-Only Content
To continue reading this article, please sign in or subscribe.
Related articles
